Regulation of hind-limb tone by adenosine A2A receptor in rats

Neuroscience

Volumn 159, Issue 4, 2009, Pages 1408-1413

  Wu, Y N ^a,b   Chen, J J J ^a   Zhang, L Q ^b   Hyland, B I ^c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b REHABILITATION INSTITUTE OF CHICAGO   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

catalepsy; CGS21680; dopamine D2; neuroleptic; Parkinsonism; rigidity

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; DOPAMINE 2 RECEPTOR; RACLOPRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; BIOMECHANICS; CATALEPSY; CONTROLLED STUDY; DRUG EFFECT; JOINT STIFFNESS; MALE; MUSCLE HYPOTONIA; MUSCLE TONE; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; RIGIDITY;

ADENOSINE; ANIMALS; BIOMECHANICS; DOPAMINE ANTAGONISTS; HINDLIMB; JOINTS; MALE; MUSCLE RIGIDITY; MUSCLE TONUS; PHENETHYLAMINES; RACLOPRIDE; RATS; RATS, WISTAR; RECEPTORS, ADENOSINE A2; RECEPTORS, DOPAMINE D2;

EID: 63349091166     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.01.068     Document Type: Article

References (42)

1. Ahlenius S., and Hillegaart V. Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission. Pharmacol Biochem Behav 24 (1986) 1409-1415
2. Basheer R., Strecker R.E., Thakkar M.M., and McCarley R.W. Adenosine and sleep-wake regulation. Prog Neurobiol 73 (2004) 379-396
3. Berardelli A., Sabra A.F., and Hallett M. Physiological mechanisms of rigidity in Parkinson's disease. J Neurol Neurosurg Psychiatry 46 (1983) 45-53
4. Bergui M., Lopiano L., Paglia G., Quattrocolo G., Scarzella L., and Bergamasco B. Stretch reflex of quadriceps femoris and its relation to rigidity in Parkinson's disease. Acta Neurol Scand 86 (1992) 226-229
5. Burke D., Hagbarth K.E., and Wallin B.G. Reflex mechanisms in parkinsonian rigidity. Scand J Rehabil Med 9 (1977) 15-23
6. Caligiuri M.P. Portable device for quantifying parkinsonian wrist rigidity. Mov Disord 9 (1994) 57-63
7. Chen J.J., Wu Y.N., Huang S.C., Lee H.M., and Wang Y.L. The use of a portable muscle tone measurement device to measure the effects of botulinum toxin type a on elbow flexor spasticity. Arch Phys Med Rehab 86 (2005) 1655-1660
8. Ferre S., Rubio A., and Fuxe K. Stimulation of adenosine A2 receptors induces catalepsy. Neurosci Lett 130 (1991) 162-164
9. Gregoric M., Stefanovska A., Vodovnik L., Rebersek S., and Gros N. Rigidity in Parkinsonism: characteristics and influences of passive exercise and electrical nerve stimulation. Funct Neurol 3 (1988) 55-68
10. Gresty M. Stability of the head in pitch (neck flexion-extension): studies in normal subjects and patients with axial rigidity. Mov Disord 4 (1989) 233-248
11. Hauber W., and Munkle M. Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen. Eur J Pharmacol 323 (1997) 127-131
12. Hauber W., Nagel J., Sauer R., and Muller C.E. Motor effects induced by a blockade of adenosine A2A receptors in the caudate-putamen. Neuroreport 9 (1998) 1803-1806
13. Heffner T.G., Wiley J.N., Williams A.E., Bruns R.F., Coughenour L.L., and Downs D.A. Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice. Psychopharmacology 98 (1989) 31-37
14. Hemsley K.M., and Crocker A.D. Raclopride and chlorpromazine, but not clozapine, increase muscle rigidity in the rat: relationship with D2 dopamine receptor occupancy. Neuropsychopharmacology 21 (1999) 101-109
15. Kolasiewicz W., Baran J., and Wolfarth S. Mechanographic analysis of muscle rigidity after morphine and haloperidol: a new methodological approach. Naunyn Schmiedebergs Arch Pharmacol 335 (1987) 449-453
16. Latash M.L. Control of human movement (1993), Human Kinetic Publishing, Champaign
17. Lee H.M., Chen J.J., Ju M.S., Lin C.C., and Poon P.P. Validation of portable muscle tone measurement device for quantifying velocity-dependent properties in elbow spasticity. J Electromyogr Kinesiol 14 (2004) 577-589
18. Lee H.M., Huang Y.Z., Chen J.J., and Hwang I.S. Quantitative analysis of the velocity related pathophysiology of spasticity and rigidity in the elbow flexors. J Neurol Neurosurg Psychiatry 72 (2002) 621-629
19. Lee R.G. Pathophysiology of rigidity and akinesia in Parkinson's disease. Eur Neurol 29 Suppl 1 (1989) 13-18
20. Lee R.G., and Tatton W.G. Motor responses to sudden limb displacements in primates with specific CNS lesions and in human patients with motor system disorders. Can J Neurol Sci 2 (1975) 285-293
21. LeWitt P.A., Guttman M., Tetrud J.W., Tuite P.J., Mori A., Chaikin P., and Sussman N.M. Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). Ann Neurol 63 (2008) 295-302
22. Lorenc-Koci E., Wolfarth S., and Ossowska K. Haloperidol-increased muscle tone in rats as a model of parkinsonian rigidity. Exp Brain Res 109 (1996) 268-276
23. Mandhane S.N., Chopde C.T., and Ghosh A.K. Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats. Eur J Pharmacol 328 (1997) 135-141
24. Marsden C.D., Merton P.A., and Morton H.B. Is the human stretch reflex cortical rather than spinal?. Lancet 1 (1973) 759-761
25. Meara R.J., and Cody F.W. Relationship between electromyographic activity and clinically assessed rigidity studied at the wrist joint in Parkinson's disease. Brain 115 4 (1992) 1167-1180
26. Mortimer J.A., and Webster D.D. Evidence for a quantitative association between EMG stretch responses and parkinsonian rigidity. Brain Res 162 (1979) 169-173
27. Richardson P.J., Kase H., and Jenner P.G. Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol Sci 18 (1997) 338-344
28. Rimondini R., Ferre S., Ogren S.O., and Fuxe K. Adenosine A2A agonists: a potential new type of atypical antipsychotic. Neuropsychopharmacology 17 (1997) 82-91
29. Rosin D.L., Robeva A., Woodard R.L., Guyenet P.G., and Linden J. Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system. J Comp Neurol 401 (1998) 163-186
30. Rothwell J.C., Obeso J.A., Traub M.M., and Marsden C.D. The behaviour of the long-latency stretch reflex in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 46 (1983) 35-44
31. Salamone J.D., Ishiwari K., Betz A.J., Farrar A.M., Mingote S.M., Font L., Hockemeyer J., Muller C.E., and Correa M. Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to Parkinsonism. Parkinsonism Relat Disord 14 Suppl 2 (2008) S130-S134
32. Shen H.Y., Coelho J.E., Ohtsuka N., Canas P.M., Day Y.J., Huang Q.Y., Rebola N., Yu L., Boison D., Cunha R.A., Linden J., Tsien J.Z., and Chen J.F. A critical role of the adenosine A2A receptor in extrastriatal neurons in modulating psychomotor activity as revealed by opposite phenotypes of striatum and forebrain A2A receptor knock-outs. J Neurosci 28 (2008) 2970-2975
33. Svenningsson P., Le Moine C., Fisone G., and Fredholm B.B. Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol 59 (1999) 355-396
34. Tatton W.G., Bedingham W., Verrier M.C., and Blair R.D. Characteristic alterations in responses to imposed wrist displacements in parkinsonian rigidity and dystonia musculorum deformans. Can J Neurol Sci 11 (1984) 281-287
35. Tatton W.G., and Lee R.G. Evidence for abnormal long-loop reflexes in rigid parkinsonian patients. Brain Res 100 (1975) 671-676
36. Teravainen H., Tsui J.K., Mak E., and Calne D.B. Optimal indices for testing parkinsonian rigidity. Can J Neurol Sci 16 (1989) 180-183
37. Wardas J., Konieczny J., and Lorenc-Koci E. The role of striatal adenosine A2A receptors in regulation of the muscle tone in rats. Neurosci Lett 276 (1999) 79-82
38. Watts R.L., Wiegner A.W., and Young R.R. Elastic properties of muscles measured at the elbow in man. II. Patients with parkinsonian rigidity. J Neurol Neurosurg Psychiatry 49 (1986) 1177-1181
39. Wolfarth S., Lorenc-Koci E., Schulze G., Ossowska K., Kaminska A., and Coper H. Age-related muscle stiffness: predominance of non-reflex factors. Neuroscience 79 (1997) 617-628
40. Wu Y.N., Huang Y., Chen J.J.J., Wang Y.L., and Piotrkiewicz M. Spasticity evaluation of hemiparetic limbs in stroke patients before intervention by using portable stretching device and EMG. J Med Biol Eng 24 (2004) 29-35
41. Wu Y.N., Hyland B.I., and Chen J.J. Biomechanical and electromyogram characterization of neuroleptic-induced rigidity in the rat. Neuroscience 147 (2007) 183-196
42. Xu K., Bastia E., and Schwarzschild M. Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease. Pharmacol Ther 105 (2005) 267-310